Publications 2024

Al Hamed R, Labopin M, Wu D, Gedde-Dahl T, Aljurf M, Forcade E, Salmenniemi U, Passweg J, Maertens J, Pabst T, Versluis J, Itäla-Remes M, Huang XJ, Van Gorkom G, Schroeder T, Sanz J, Blaise D, Reményi P, Schanz U, Esteve J, Gorin NC, Ciceri F, Mohty M (2024)
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
Bone Marrow Transplant, 59 (10), 1458-1465
DOI 10.1038/s41409-024-02373-5, PubMed 39095548

Arrieta-Bolaños E, Bonneville EF, Crivello P, Robin M, Gedde-Dahl T, Salmenniemi U, Kröger N, Yakoub-Agha I, Crawley C, Choi G, Broers AEC, Forcade E, Carre M, Poiré X, Huynh A, Lenhoff S, Ciceri F, Tholouli E, Schroeder T, Deconinck E, Carlson K, de Wreede LC, Hoogenboom JD, Malard F, Ruggeri A et al. (2024)
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
J Clin Oncol, 42 (28), 3287-3299
DOI 10.1200/JCO.24.00582, PubMed 39167735

Arrieta-Bolaños E, van der Burg LLJ, Gedde-Dahl T, Robin M, Salmenniemi U, Kröger N, Yakoub-Agha I, Huynh A, Crawley C, Deconinck E, Bulabois CE, Forcade E, Tholouli E, van der Hem JGK, van Balen P, Hoogenboom JD, de Wreede LC, Malard F, Ruggeri A, Fleischhauer K (2024)
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
Blood, 144 (16), 1747-1751
DOI 10.1182/blood.2024024351, PubMed 39102621

Blum S, Chalandon Y, Labopin M, Finke J, Gedde-Dahl T, Othman TB, Cornelissen JJ, Jindra P, Labussière-Wallet H, Collin M, Lenhoff S, Kobbe G, Gutiérrez NC, Nagler A, Mohty M (2024)
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Haematologica, 109 (7), 2346-2350
DOI 10.3324/haematol.2023.284858, PubMed 38450525

Brune M, Kiss T, Anderson H, Nicklasson M, Delage R, Finke J, Gedde-Dahl T, Hébert J, Höglund M, Kaare A, Lazarevic V, Möllgård L, Remes K, Ritchie D, Spyridonidis A, Sabloff M, Spearing R, Wallhult E, Ljungman P (2024)
Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50-70 year old AML patients
Bone Marrow Transplant (in press)
DOI 10.1038/s41409-024-02408-x, PubMed 39223244

Chalandon Y, Eikema DJ, Moiseev I, Ciceri F, Koster L, Vydra J, Passweg J, Rovira M, Ozcelik T, Gedde-Dahl T, Kröger N, Potter V, Yakoub-Agha I, Rambaldi A, Itälä-Remes M, Tanase A, Onida F, Gurnari C, Scheid C, Drozd-Sokolowska J, Raj K, McLornan DP, Robin M (2024)
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms
Blood Adv, 8 (18), 4792-4802
DOI 10.1182/bloodadvances.2024013468, PubMed 39008719

Drozd-Sokolowska J, Gras L, Koster L, Martino R, Salas MQ, Salmenniemi U, Zudaire T, Yañez L, Bellido M, Collin M, Kaufmann M, Kozlowski P, Poiré X, Ferra C, Sampol A, Wilson KMO, Cairoli A, Gedde-Dahl T, Deconinck E, Mirabile M, Suarez F, Raj K, Van Gelder M, Yakoub-Agha I, Tournilhac O et al. (2024)
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Haematologica, 109 (5), 1608-1613
DOI 10.3324/haematol.2023.284359, PubMed 38205539

Fageräng B, Cyranka L, Schjalm C, McAdam KE, Larsen CS, Heinzelbecker J, Gedde-Dahl T, Würzner R, Espevik T, Tjønnfjord GE, Garred P, Barratt-Due A, Tvedt THA, Mollnes TE (2024)
The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation
Front Immunol, 15, 1422370
DOI 10.3389/fimmu.2024.1422370, PubMed 38938578

Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
Leukemia, 38 (4), 781-787
DOI 10.1038/s41375-024-02145-6, PubMed 38278960

Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U (2024)
Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial
Leukemia, 38 (4), 925
DOI 10.1038/s41375-024-02184-z, PubMed 38418611

Giebel S, Labopin M, Peric Z, Passweg J, Blaise D, Salmenniemi U, Beauvais D, Reményi P, Chevallier P, Mielke S, Gedde-Dahl T, Cornelissen JJ, Balsat M, Bug G, Bazarbachi A, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT
Transplant Cell Ther (in press)
DOI 10.1016/j.jtct.2024.07.016, PubMed 39069077

Grønvold BL, Ali MM, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IW, Tjønnfjord GE, Myhre AE, Fløisand Y, Gedde-Dahl T (2024)
Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
EJHaem, 5 (1), 117-124
DOI 10.1002/jha2.842, PubMed 38406518

Guièze R, Eikema DJ, Koster L, Schetelig J, Sengeloev H, Passweg J, Finke J, Arat M, Broers AEC, Stölzel F, Byrne J, Castilla-Llorente C, Dreger P, Eder M, Gedde-Dahl T, Kröger N, Ribera Santasusana JM, Richardson D, Rambaldi A, Yañez L, Van Gelder M, Drozd-Sokolowska J, Raj K, Yakoub-Agha I, Tournilhac O et al. (2024)
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Bone Marrow Transplant, 59 (7), 950-956
DOI 10.1038/s41409-024-02256-9, PubMed 38503942

Holland P, Istre M, Ali MM, Gedde-Dahl T, Buechner J, Wildhagen M, Brunvoll SH, Horvath S, Matsuyama S, Dahl JA, Stölzel F, Søraas A (2024)
Epigenetic aging of human blood cells is influenced by the age of the host body
Aging Cell, 23 (5), e14112
DOI 10.1111/acel.14112, PubMed 38439206

Loke J, Labopin M, Craddock C, Socié G, Gedde-Dahl T, Blaise D, Forcade E, Salmenniemi U, Huynh A, Versluis J, Yakoub-Agha I, Labussière-Wallet H, Maertens J, Passweg J, Bulabois CE, Gabellier L, Mielke S, Castilla-Llorente C, Deconinck E, Brissot E, Nagler A, Ciceri F, Mohty M (2024)
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
Cancer, 130 (15), 2642-2651
DOI 10.1002/cncr.35308, PubMed 38581695

McDonald GB, Landsverk OJB, McGovern DPB, Aasebø A, Paulsen V, Haritunians T, Reims HM, McLaughlin BM, Zisman T, Li D, Elholm ETMM, Jahnsen FL, Georges GE, Gedde-Dahl T (2024)
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease
Heliyon, 10 (1), e24026
DOI 10.1016/j.heliyon.2024.e24026, PubMed 38283244

Mohty R, Bazarbachi AH, Labopin M, Esteve J, Kröger N, Cornelissen JJ, Blaise D, Socié G, Maury S, Ganser A, Gedde-Dahl T, von dem Borne P, Bourhis JH, Bulabois CE, Yakoub-Agha I, Pabst C, Nguyen S, Chevallier P, Huynh A, Bazarbachi A, Nagler A, Ciceri F, Mohty M (2024)
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT
Bone Marrow Transplant, 59 (11), 1534-1541
DOI 10.1038/s41409-024-02384-2, PubMed 39143183

Montoro J, Eikema DJ, Tuffnell J, Potter V, Kalwak K, Halkes CJM, Kulagin A, Collin M, Wynn RF, Robinson S, Nicholson E, Sengeloev H, Clay J, Halahleh K, Skorobogatova E, Sanz J, Passweg J, Mielke S, Ryhänen S, Carpenter B, Gedde-Dahl T, Tholouli E, Fanin R, Lewalle P, Kulasekararaj A et al. (2024)
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT
Blood, 144 (3), 323-333
DOI 10.1182/blood.2024024173, PubMed 38643511

Moukalled N, Labopin M, Versluis J, Socié G, Blaise D, Salmenniemi U, Rambaldi A, Gedde-Dahl T, Tholouli E, Kröger N, Bourhis JH, Von Dem Borne P, Daguindau E, Forcade E, Nagler A, Esteve J, Ciceri F, Bazarbachi A, Mohty M (2024)
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1-mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
Am J Hematol, 99 (3), 360-369
DOI 10.1002/ajh.27187, PubMed 38165072

Nagler A, Labopin M, Swoboda R, Schroeder T, Hamladji RM, Griskevicius L, Salmenniemi U, Rambaldi A, Mielke S, Kulagin A, Passweg J, Luft T, Gedde-Dahl T, Forcade E, Helbig G, Stelljes M, Castilla-Llorente C, Spyridonidis A, Brissot E, Ciceri F, Mohty M (2024)
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Bone Marrow Transplant, 59 (7), 1012-1021
DOI 10.1038/s41409-024-02284-5, PubMed 38615143

Nagler A, Ngoya M, Galimard JE, Labopin M, Blau IW, Kröger N, Gedde-Dahl T, Schroeder T, Burns D, Salmenniemi U, Rambaldi A, Choi G, Peffault de Latour R, Vydra J, Sengeloev H, Eder M, Mielke S, Forcade E, Kulagin A, Ciceri F, Mohty M (2024)
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Am J Hematol, 99 (9), 1732-1745
DOI 10.1002/ajh.27383, PubMed 38856236

Penack O, Abouqateb M, Peczynski C, Boreland W, Gülbas Z, Gedde-Dahl T, Castilla-Llorente C, Kröger N, Eder M, Rambaldi A, Bonifazi F, Blau IW, Stelljes M, Dreger P, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
Blood Cancer J, 14 (1), 45
DOI 10.1038/s41408-024-01032-8, PubMed 38485723

Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Stelljes M, Gedde-Dahl T, Blau IW, Schroeder T, Salmenniemi U, Kulagin A, Peffault de Latour R, Mielke S, Zeiser R, Moiseev I, Schoemans H, Koenecke C, Peric Z (2024)
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Leukemia, 38 (5), 1156-1163
DOI 10.1038/s41375-024-02225-7, PubMed 38538862

Scheid C, Eikema DJ, van Gelder M, Salmenniemi U, Maertens J, Passweg J, Blaise D, Byrne JL, Kröger N, Sockel K, Chevallier P, Bourhis JH, Cornelissen JJ, Sengeloev H, Finke J, Snowden JA, Gedde-Dahl T, Cornillon J, Schanz U, Patel A, Koster L, de Wreede LC, Hayden P, Raj K, Drozd-Sokolowska J et al. (2024)
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
Blood, 144 (4), 445-456
DOI 10.1182/blood.2023022273, PubMed 38728380

Styczynski J, Tridello G, Knelange N, Wendel L, Ljungman P, Mikulska M, Gil L, Cesaro S, Averbuch D, von dem Borne P, Xhaard A, Mielke S, Neven B, Snowden JA, Dalle JH, Rubio MT, Crawley C, Maertens J, Kuball J, Chevallier P, Michel G, Gabriel M, Burns D, Wynn RF, Renard C et al. (2024)
Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Bone Marrow Transplant, 59 (10), 1402-1412
DOI 10.1038/s41409-024-02361-9, PubMed 38987308

Vethe NT, Andersen AM, Gedde-Dahl T, Büchner J, Bergan S (2024)
Therapeutic Drug Monitoring of Intravenous Busulfan and Analytical Challenges due to the Drug Formulation Excipient PEG 400: Letter to the Editor
Ther Drug Monit, 46 (3), 416-417
DOI 10.1097/FTD.0000000000001209, PubMed 38648662

Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl T, Blaise D, Socie G, Forcade E, Salmenniemi U, Maury S, Versluis J, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT
Blood Cancer J, 14 (1), 85
DOI 10.1038/s41408-024-01072-0, PubMed 38802349

Ye Y, Labopin M, Gérard S, Yakoub-Agha I, Blau IW, Aljurf M, Forcade E, Gedde-Dahl T, Burns D, Vydra J, Halahleh K, Hamladji RM, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Zhao Y, Ciceri F, Huang H, Mohty M, Gorin NC (2024)
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Am J Hematol, 99 (7), 1290-1299
DOI 10.1002/ajh.27342, PubMed 38654658

Publications 2023

Al Hamed R, Ngoya M, Galimard JE, Sengeloev H, Gedde-Dahl T, Kulagin A, Platzbecker U, Yakoub-Agha I, Byrne JL, Valerius T, Socie G, Kröger N, Blaise D, Bazarbachi A, Sanz J, Ciceri F, Nagler A, Mohty M (2023)
Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study
Cancer, 129 (17), 2645-2654
DOI 10.1002/cncr.34843, PubMed 37269074

Ali MM, Gedde-Dahl T, Osnes LT, Perrier F, Veierød MB, Tjønnfjord GE, Iversen PO (2023)
Extracorporeal Photopheresis as Graft-versus-Host Disease Prophylaxis: A Randomized Controlled Trial
Transplant Cell Ther, 29 (6), 364.e1-364.e11
DOI 10.1016/j.jtct.2023.02.023, PubMed 36878428

Bazarbachi A, Labopin M, Gedde-Dahl T, Remenyi P, Forcade E, Kröger N, Socié G, Craddock C, Bourhis JH, Versluis J, Yakoub-Agha I, Salmenniemi U, El-Cheikh J, Bug G, Esteve J, Nagler A, Ciceri F, Mohty M (2023)
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party
Clin Cancer Res, 29 (21), 4441-4448
DOI 10.1158/1078-0432.CCR-23-0954, PubMed 37603683

Federico L, Tvedt THA, Gainullin M, Osen JR, Chaban V, Lund KP, Tietze L, Tran TT, Lund-Johansen F, Kared H, Lind A, Vaage JT, Stratford R, Tennøe S, Malone B, Clancy T, Myhre AEL, Gedde-Dahl T, Munthe LA (2023)
Robust spike-specific CD4⁺ and CD8⁺ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
Front Immunol, 14, 1210899
DOI 10.3389/fimmu.2023.1210899, PubMed 37503339

Geelen IGP, Gullaksen SE, Ilander MM, Olssen-Strömberg U, Mustjoki S, Richter J, Blijlevens NMA, Smit WM, Gjertsen BT, Gedde-Dahl T, Markevärn B, Koppes MMA, Westerweel PE, Hjorth-Hansen H, Janssen JJWM (2023)
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
Ann Hematol, 102 (6), 1395-1408
DOI 10.1007/s00277-023-05199-1, PubMed 37119314

Giannakopoulou E, Lehander M, Virding Culleton S, Yang W, Li Y, Karpanen T, Yoshizato T, Rustad EH, Nielsen MM, Bollineni RC, Tran TT, Delic-Sarac M, Gjerdingen TJ, Douvlataniotis K, Laos M, Ali M, Hillen A, Mazzi S, Chin DWL, Mehta A, Holm JS, Bentzen AK, Bill M, Griffioen M, Gedde-Dahl T et al. (2023)
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
Nat Cancer, 4 (10), 1474-1490
DOI 10.1038/s43018-023-00642-8, PubMed 37783807

Gjærde LK, Ruutu T, Peczynski C, Boreland W, Kröger N, Blaise D, Schroeder T, Peffault de Latour R, Gedde-Dahl T, Kulagin A, Sengeløv H, Yakoub-Agha I, Finke J, Eder M, Basak G, Moiseev I, Schoemans H, Koenecke C, Penack O, Perić Z (2023)
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party
Bone Marrow Transplant, 59 (2), 255-263
DOI 10.1038/s41409-023-02154-6, PubMed 38062242

Hernández-Boluda JC, Eikema DJ, Koster L, Kröger N, Robin M, de Witte M, Finke J, Finazzi MC, Broers A, Raida L, Schaap N, Chiusolo P, Verbeek M, Hazenberg CLE, Halaburda K, Kulagin A, Labussière-Wallet H, Gedde-Dahl T, Rabitsch W, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, Yakoub-Agha I et al. (2023)
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Bone Marrow Transplant, 58 (12), 1357-1367
DOI 10.1038/s41409-023-02094-1, PubMed 37679647

Nagler A, Labopin M, Kröger N, Schroeder T, Gedde-Dahl T, Eder M, Franke GN, Blau IW, Salmenniemi U, Socie G, Schetelig J, Stelljes M, Ciceri F, Mohty M (2023)
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT
Bone Marrow Transplant, 58 (12), 1339-1347
DOI 10.1038/s41409-023-02095-0, PubMed 37660157

Nagler A, Labopin M, Mielke S, Passweg J, Blaise D, Gedde-Dahl T, Cornelissen JJ, Salmenniemi U, Yakoub-Agha I, Reményi P, Socié G, van Gorkom G, Labussière-Wallet H, Huang XJ, Rubio MT, Byrne J, Craddock C, Griškevičius L, Ciceri F, Mohty M (2023)
Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT
Bone Marrow Transplant, 58 (7), 791-800
DOI 10.1038/s41409-023-01980-y, PubMed 37045942

Poiré X, Labopin M, Polge E, Ganser A, Socié G, Gedde-Dahl T, Forcade E, Finke J, Chalandon Y, Bulabois CE, Yakoub-Agha I, Aljurf M, Kröger N, Blau IW, Nagler A, Esteve J, Mohty M (2023)
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype
Bone Marrow Transplant, 59 (2), 264-269
DOI 10.1038/s41409-023-02167-1, PubMed 38092959

Ruggeri A, De Wreede LC, Müller CR, Crivello P, Bonneville EF, Petersdorf EW, Socié G, Dubois V, Niittyvuopio R, Peräsaari J, Yakoub-Agha I, Cornelissen JJ, Wieten L, Gedde-Dahl T, Forcade E, Crawley CR, Marsh SGE, Gandemer V, Tholouli E, Bulabois CE, Huynh A, Choi G, Deconinck E, Itäla-Remes M, Lenhoff S et al. (2023)
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
Haematologica, 108 (2), 645-652
DOI 10.3324/haematol.2021.280055, PubMed 35546480

Rørvik SD, Abrahamsen IW, Myhre AE, Vo CD, Ødegaard EM, Bruserud Ø, Gedde-Dahl T, Tvedt THA (2023)
[Chronic graft-versus-host disease]
Tidsskr Nor Laegeforen, 143 (4)
DOI 10.4045/tidsskr.22.0525, PubMed 36919292

Sanz J, Labopin M, Pabst T, Versluis J, Van Gorkom G, Meijer E, Gedde-Dahl T, Montoro J, Arcese W, Pérez-Simón JA, Schaap N, Maertens J, Vrhovac R, Lanza F, Gorin NC, Mohty M, Ciceri F (2023)
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplant, 58 (11), 1197-1202
DOI 10.1038/s41409-023-02075-4, PubMed 37553468

Spyridonidis A, Labopin M, Gedde-Dahl T, Ganser A, Stelljes M, Craddock C, Wagner-Drouet EM, Versluis J, Schroeder T, Blau IW, Wulf GG, Dreger P, Olesen G, Sengeloev H, Kröger N, Potter V, Forcade E, Passweg J, de Latour RP, Maertens J, Wilson KMO, Bourhis JH, Finke J, Brissot E, Bazarbachi A et al. (2023)
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 59 (2), 217-223
DOI 10.1038/s41409-023-02139-5, PubMed 37978322

Vo CD, Myhre AE, Abrahamsen IW, Remberger M, Mattsson J, Fløisand Y, Grønvold BCL, Tjønnfjord GE, Tvedt THA, Gedde-Dahl T (2023)
Allogeneic stem cell transplantation in adults 2015-21
Tidsskr Nor Laegeforen, 143 (4)
DOI 10.4045/tidsskr.22.0521, PubMed 36919291

Publications 2022

Albert MH, Sirait T, Eikema DJ, Bakunina K, Wehr C, Suarez F, Fox ML, Mahlaoui N, Gennery AR, Lankester AC, Beier R, Bernardo ME, Bigley V, Lindemans CA, Burns SO, Carpenter B, Dybko J, Güngör T, Hauck F, Lum SH, Balashov D, Meisel R, Moshous D, Schulz A, Speckmann C et al. (2022)
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study
Blood, 140 (14), 1635-1649
DOI 10.1182/blood.2022015506, PubMed 35344580

Garcia-Horton A, Cyriac SL, Gedde-Dahl T, Floisand Y, Remberger M, Mattsson J, Michelis FV (2022)
Patient age and donor HLA matching can stratify allogeneic hematopoietic cell transplantation patients into prognostic groups
Eur J Haematol, 109 (6), 672-679
DOI 10.1111/ejh.13850, PubMed 36028979

Horn MA, Myhre AE, Prescott T, Aasly J, Sundal CH, Gedde-Dahl T (2022)
Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related Leukoencephalopathy
Mov Disord, 37 (5), 1108-1109
DOI 10.1002/mds.29011, PubMed 35587623

Huuhtanen J, Ilander M, Yadav B, Dufva OM, Lähteenmäki H, Kasanen T, Klievink J, Olsson-Strömberg U, Stentoft J, Richter J, Koskenvesa P, Höglund M, Söderlund S, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Stenke L, Myhr-Eriksson K, Markevärn B, Lübking A, Dimitrijevic A, Udby L, Bjerrum OW, Hjorth-Hansen H et al. (2022)
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
J Clin Invest, 132 (17)
DOI 10.1172/JCI152585, PubMed 36047494

Nagler A, Galimard JE, Labopin M, Blaise D, Arcese W, Trisolini SM, Wu D, Pigneux A, Van Gorkom G, Rubio MT, Gedde-Dahl T, Huynh A, Lanza F, Gorin NC, Mohty M (2022)
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT
Cancer Med, 12 (2), 1482-1491
DOI 10.1002/cam4.5039, PubMed 35891608

Nagler A, Labopin M, Craddock C, Socié G, Yakoub-Agha I, Gedde-Dahl T, Niittyvuopio R, Byrne JL, Cornelissen JJ, Labussière-Wallet H, Arcese W, Milpied N, Esteve J, Canaani J, Mohty M (2022)
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation
Am J Hematol, 97 (3), 274-282
DOI 10.1002/ajh.26442, PubMed 34978724

Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
Bone Marrow Transplant, 57 (12), 1788-1796
DOI 10.1038/s41409-022-01825-0, PubMed 36114249

Nagler A, Ngoya M, Galimard JE, Labopin M, Kröger N, Socié G, Gedde-Dahl T, Potter V, Schroeder T, Platzbecker U, Ganser A, Blaise D, Salmenniemi U, Maertens J, Craddock C, Labussière-Wallet H, Yakoub-Agha I, Savani B, Mohty M (2022)
Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
Bone Marrow Transplant, 57 (12), 1856
DOI 10.1038/s41409-022-01853-w, PubMed 36280759

Swan D, Hayden PJ, Eikema DJ, Koster L, Sauer S, Blaise D, Nicholson E, Rabin N, Touzeau C, Byrne J, Huynh A, Cornelissen JJ, Potter V, Forcade E, Parrish C, Gribben J, Chretien ML, Mielke S, Gedde-Dahl T, Reményi P, Tsirigotis P, Garcia Guiñón A, Beksac M, Schönland S, Yakoub-Agha I (2022)
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
Br J Haematol, 197 (1), 82-96
DOI 10.1111/bjh.18025, PubMed 35166376

Tvedt THA, Rose-John S, Tsykunova G, Ahmed AB, Gedde-Dahl T, Ersvær E, Bruserud Ø (2022)
IL-6 Responsiveness of CD4⁺ and CD8⁺ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy
J Clin Med, 11 (9)
DOI 10.3390/jcm11092530, PubMed 35566660

Aasebo AT, Gedde-Dahl T, Reims HM, Baekkevold ES, Jahnsen FL (2022)
Calprotectin Expressing Donor-Derived Macrophages Increase in Acute Gastrointestinal Graft-Versus-Host Disease
Transplant Cell Ther, 28 (5), 248.e1-248.e8
DOI 10.1016/j.jtct.2022.01.028, PubMed 35144036

Publications 2021

Ali MM, Grønvold B, Remberger M, Abrahamsen IW, Myhre AE, Tjønnfjord GE, Fløisand Y, Gedde-Dahl T (2021)
Addition of Anti-thymocyte Globulin in Allogeneic Stem Cell Transplantation With Peripheral Stem Cells From Matched Unrelated Donors Improves Graft-Versus-Host Disease and Relapse Free Survival
Clin Lymphoma Myeloma Leuk, 21 (9), 598-605
DOI 10.1016/j.clml.2021.05.003, PubMed 34158268

Andersen AM, Bergan S, Gedde-Dahl T, Buechner J, Vethe NT (2021)
Fast and reliable quantification of busulfan in blood plasma using two-channel liquid chromatography tandem mass spectrometry: Validation of assay performance in the presence of drug formulation excipients
J Pharm Biomed Anal, 203, 114216
DOI 10.1016/j.jpba.2021.114216, PubMed 34182411

Cesaro S, Tridello G, Knelange NS, Blijlevens N, Martin M, Snowden JA, Malladi R, Ljungman P, Deconinck E, Gedde-Dahl T, Byrne J, Xhaard A, Chevallier P, Maertens J, Zuckerman T, Lioure B, Petersen E, Cornelissen JJ, Arcese W, Blaise D, Milpied N, Cahn JY, Aljurf M, de Wreede L, Mauro M et al. (2021)
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT
Bone Marrow Transplant, 56 (7), 1563-1572
DOI 10.1038/s41409-021-01212-1, PubMed 33514919

Flygt H, Söderlund S, Stentoft J, Richter J, Koskenvesa P, Mustjoki S, Majeed W, Lübking A, Dreimane A, Markevärn B, Stenke L, Myhr Eriksson K, Gjertsen BT, Gedde-Dahl T, Dimitrijevic A, Udby L, Olsson-Strömberg U, Hjorth-Hansen H (2021)
Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study
Eur J Haematol, 107 (6), 617-623
DOI 10.1111/ejh.13699, PubMed 34418168

Jørgensen SF, Buechner J, Myhre AE, Galteland E, Spetalen S, Kulseth MA, Sorte HS, Holla ØL, Lundman E, Alme C, Heier I, Flægstad T, Fløisand Y, Benneche A, Fevang B, Aukrust P, Stray-Pedersen A, Gedde-Dahl T, Nordøy I (2021)
A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT
J Clin Immunol, 42 (2), 404-420
DOI 10.1007/s10875-021-01189-y, PubMed 34893945

Kharfan-Dabaja MA, Labopin M, Bazarbachi A, Ciceri F, Finke J, Bruno B, Bornhäuser M, Gedde-Dahl T, Labussière-Wallet H, Niittyvuopio R, Valerius T, Angelucci E, Brecht A, Caballero D, Kuball J, Potter V, Schmid C, Tischer J, Zuckerman T, Benedetti F, Blaise D, Diez-Martin JL, Sanz J, Ruggeri A, Brissot E et al. (2021)
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT
Bone Marrow Transplant, 56 (9), 2194-2202
DOI 10.1038/s41409-021-01317-7, PubMed 33931757

Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, Bondarenko S, Bourhis JH, Cornelissen JJ, Socié G, Koc Y, Canaani J, Savani B, Bug G, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M (2021)
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation
Transplant Cell Ther, 28 (2), 86.e1-86.e8
DOI 10.1016/j.jtct.2021.11.013, PubMed 34856420

Remberger M, Tjønnfjord GE, Abrahamsen IW, Ali M, Myhre AE, Gedde-Dahl T, Fløisand Y (2021)
Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
Transplant Cell Ther, 27 (7), 621.e1-621.e3
DOI 10.1016/j.jtct.2021.03.019, PubMed 33895156

Richter J, Lübking A, Söderlund S, Lotfi K, Markevärn B, Själander A, Stenke L, Deneberg S, Ahlstrand E, Myhr-Eriksson K, Panayiotidis P, Gedde-Dahl T, Žáčková D, Mayer J, Olsson-Strömberg U, Mahon FX, Saussele S, Hjorth-Hansen H, Koskenvesa P (2021)
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
Leukemia, 35 (8), 2416-2418
DOI 10.1038/s41375-021-01173-w, PubMed 33589755

Waidhauser J, Labopin M, Esteve J, Kröger N, Cornelissen J, Gedde-Dahl T, Van Gorkom G, Finke J, Rovira M, Schaap N, Petersen E, Beelen D, Bunjes D, Savani B, Schmid C, Nagler A, Mohty M, Acute Leukemia Working Party of EBMT (2021)
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
Bone Marrow Transplant, 56 (10), 2445-2453
DOI 10.1038/s41409-021-01322-w, PubMed 34059800

Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F, REACH3 Investigators (2021)
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
N Engl J Med, 385 (3), 228-238
DOI 10.1056/NEJMoa2033122, PubMed 34260836

Publications 2020

Divito SJ, Aasebø AT, Matos TR, Hsieh PC, Collin M, Elco CP, O'Malley JT, Bækkevold ES, Reims H, Gedde-Dahl T, Hagerstrom M, Hilaire J, Lian JW, Milford EL, Pinkus GS, Ho VT, Soiffer RJ, Kim HT, Mihm MC, Ritz J, Guleria I, Cutler CS, Clark RA, Jahnsen FL, Kupper TS (2020)
Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease
J Clin Invest, 130 (9), 4624-4636
DOI 10.1172/JCI129965, PubMed 32516138

Grønvold B, Ali MM, Remberger M, Mattsson J, Egeland T, Lundin KU, Myhre AE, Abrahamsen IW, Heldal D, Dybedal I, Tjønnfjord GE, Fløisand Y, Gedde-Dahl T (2020)
HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation
Bone Marrow Transplant, 55 (8), 1658-1661
DOI 10.1038/s41409-020-0827-3, PubMed 32054997

Remberger M, Grønvold B, Ali M, Mattsson J, Egeland T, Lundin KU, Myhre A, Abrahamsen I, Heldal D, Dybedal I, Tjønnfjord GE, Gedde-Dahl T, Fløisand Y (2020)
The CD34⁺ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
Clin Hematol Int, 2 (2), 74-81
DOI 10.2991/chi.d.200221.001, PubMed 34595446

Tadele DS, Robertson J, Crispin R, Herrera MC, Chlubnová M, Piechaczyk L, Ayuda-Durán P, Singh SK, Gedde-Dahl T, Fløisand Y, Skavland J, Wesche J, Gjertsen BT, Enserink JM (2020)
A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation
J Biol Chem, 296, 100179
DOI 10.1074/jbc.RA120.015285, PubMed 33303632

Weum Abrahamsen I, Grønvold BC, Inderberg EM, Mensali N, Mattsson J, Gedde-Dahl T (2020)
Posttransplantation Lymphoproliferative Disease Treated by Retransplantation
Case Reports Immunol, 2020, 9403123
DOI 10.1155/2020/9403123, PubMed 32158568

Publications 2019

Cremers EMP, de Witte T, de Wreede L, Eikema DJ, Koster L, van Biezen A, Finke J, Socié G, Beelen D, Maertens J, Nagler A, Kobbe G, Ziagkos D, Itälä-Remes M, Gedde-Dahl T, Sierra J, Niederwieser D, Ljungman P, Beguin Y, Ozkurt ZN, Anagnostopoulos A, Jindra P, Robin M, Kröger N (2019)
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
Leuk Lymphoma, 60 (10), 2404-2414
DOI 10.1080/10428194.2019.1594215, PubMed 30997844

Gilleece MH, Labopin M, Savani BN, Yakoub-Agha I, Socié G, Gedde-Dahl T, Blaise D, Byrne JL, Craddock C, Cornelissen JJ, Arcese W, Forcade E, Crawley C, Polge E, Mohty M, Nagler A (2019)
Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT
Leukemia, 34 (1), 87-99
DOI 10.1038/s41375-019-0527-4, PubMed 31363160

Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A (2019)
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Haematologica, 105 (6), 1723-1730
DOI 10.3324/haematol.2019.222810, PubMed 31439677

Passweg JR, Labopin M, Christopeit M, Cornelissen J, Pabst T, Socié G, Russel N, Yakoub-Agha I, Blaise D, Gedde-Dahl T, Labussière-Wallet H, Malladi R, Forcade E, Maury S, Polge E, Lanza F, Gorin NC, Mohty M, Nagler A (2019)
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Biol Blood Marrow Transplant, 26 (4), 659-664
DOI 10.1016/j.bbmt.2019.11.021, PubMed 31759159

Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
Aging Cell, 18 (2), e12897
DOI 10.1111/acel.12897, PubMed 30712319

Tvedt THA, Skaarud KJ, Tjønnfjord GE, Gedde-Dahl T, Iversen PO, Bruserud Ø (2019)
The Systemic Metabolic Profile Early after Allogeneic Stem Cell Transplantation: Effects of Adequate Energy Support Administered through Enteral Feeding Tube
Biol Blood Marrow Transplant, 26 (2), 380-391
DOI 10.1016/j.bbmt.2019.10.005, PubMed 31622769

Wiktor-Jedrzejczak W, Drozd-Sokolowska J, Eikema DJ, Hoek J, Potter M, Wulf G, Sellner L, Ljungman P, Chevallier P, Volin L, Koc Y, Martin S, Bunjes D, Rovira M, Itälä-Remes M, Foá R, Deconinck E, Gedde-Dahl T, Cornelissen J, Collin M, Brecht A, Patel A, de Groot M, Reményi P, Nagler A et al. (2019)
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
Bone Marrow Transplant, 54 (9), 1391-1398
DOI 10.1038/s41409-019-0448-x, PubMed 30664723

Publications 2018

Bruserud Ø, Melve GK, Gedde-Dahl T, Tvedt THA (2018)
Immunological heterogeneity of healthy peripheral blood stem cell donors - preharvesting donor characteristics, additional heterogeneity induced by granulocyte colony-stimulating factor and possible importance for outcome after allotransplantation
Expert Rev Hematol, 11 (10), 757-759
DOI 10.1080/17474086.2018.1511420, PubMed 30126308

Danylesko I, Bukauskas A, Paulson M, Peceliunas V, Gedde-Dahl D Y T, Shimoni A, Shouval R, Griskevicius L, Floisand Y, Nagler A (2018)
Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease
Bone Marrow Transplant, 54 (7), 987-993
DOI 10.1038/s41409-018-0364-5, PubMed 30356163

Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
Bone Marrow Transplant, 53 (5), 657-660
DOI 10.1038/s41409-018-0091-y, PubMed 29358600

Fevang B, Fagerli UM, Sorte H, Aarset H, Hov H, Langmyr M, Keil TM, Bjørge E, Aukrust P, Stray-Pedersen A, Gedde-Dahl T (2018)
Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas
Case Reports Immunol, 2018, 2053716
DOI 10.1155/2018/2053716, PubMed 29888014

Lorentino F, Labopin M, Bernardi M, Ciceri F, Socié G, Cornelissen JJ, Esteve J, Ruggeri A, Volin L, Yacoub-Agha I, Craddock C, Passweg J, Blaise D, Gedde-Dahl T, Poiani M, Fegueux N, Mohty M, Nagler A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018)
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission
Am J Hematol, 93 (10), 1236-1244
DOI 10.1002/ajh.25231, PubMed 30058714

McLornan DP, Szydlo R, Robin M, van Biezen A, Koster L, Blok HJP, Van Lint MT, Finke J, Vitek A, Carlson K, Griskevicius L, Holler E, Itälä-Remes M, Schaap M, Socié G, Bay JO, Beguin Y, Bruno B, Cornelissen JJ, Gedde-Dahl T, Ljungman P, Rubio MT, Yakoub-Agha I, Klyuchnikov E, Olavarria E et al. (2018)
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
Br J Haematol, 182 (3), 418-422
DOI 10.1111/bjh.15407, PubMed 29808926

Reikvam H, Skavland J, Gullaksen SE, Hovland R, Gedde-Dahl T, Bruserud Ø, Gjertsen BT (2018)
Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation
Case Rep Hematol, 2018, 2045985
DOI 10.1155/2018/2045985, PubMed 30345125

Tangen JM, Tjønnfjord GE, Gulbrandsen N, Gedde-Dahl T, Stormorken E, Anderson K, Vo CD, Schjesvold FH, For Oslo Myeloma Center (2018)
Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis
BMC Cancer, 18 (1), 801
DOI 10.1186/s12885-018-4722-x, PubMed 30089450

Tvedt THA, Hovland R, Tsykunova G, Ahmed AB, Gedde-Dahl T, Bruserud Ø (2018)
A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation
Clin Exp Immunol, 193 (1), 130-141
DOI 10.1111/cei.13124, PubMed 29513361

Publications 2017

Canaani J, Beohou E, Labopin M, Socié G, Huynh A, Volin L, Cornelissen J, Milpied N, Gedde-Dahl T, Deconinck E, Fegueux N, Blaise D, Mohty M, Nagler A (2017)
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT
Am J Hematol, 92 (4), 344-350
DOI 10.1002/ajh.24640, PubMed 28052366

Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A (2017)
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT
Am J Hematol, 92 (7), 653-659
DOI 10.1002/ajh.24737, PubMed 28370339

Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, Ferrant A, Gedde-Dahl T, Hellmann A, Janssen J, Labar B, Lang A, Majeed W, Mihaylov G, Stentoft J, Stenke L, Thaler J, Thielen N, Verhoef G, Voglova J, Ossenkoppele G, Hochhaus A, Hjorth-Hansen H, Mustjoki S, Sopper S et al. (2017)
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib
Haematologica, 102 (8), 1361-1367
DOI 10.3324/haematol.2017.167080, PubMed 28522574

Lazarevic VL, Labopin M, Depei W, Yakoub-Agha I, Huynh A, Ljungman P, Schaap N, Cornelissen JJ, Maillard N, Pioltelli P, Gedde-Dahl T, Lenhoff S, Houhou M, Esteve J, Mohty M, Nagler A (2017)
Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT)
Am J Hematol, 93 (1), 31-39
DOI 10.1002/ajh.24928, PubMed 28971504

Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2017)
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
Bone Marrow Transplant, 52 (7), 1081
DOI 10.1038/bmt.2017.86, PubMed 28677682

Publications 2016

Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T (2016)
Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
Biol Blood Marrow Transplant, 23 (1), 172-175
DOI 10.1016/j.bbmt.2016.10.009, PubMed 27777142

Hjorth-Hansen H, Stentoft J, Richter J, Koskenvesa P, Höglund M, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Gruber FX, Stenke L, Eriksson KM, Markevärn B, Lübking A, Vestergaard H, Udby L, Bjerrum OW, Persson I, Mustjoki S, Olsson-Strömberg U (2016)
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
Leukemia, 30 (9), 1853-60
DOI 10.1038/leu.2016.121, PubMed 27133821

Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, Markevärn B, Själander A, Lotfi K, Dreimane A, Lübking A, Holm E, Björeman M, Lehmann S, Stenke L, Ohm L, Gedde-Dahl T, Majeed W, Ehrencrona H, Koskela S, Saussele S et al. (2016)
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Leukemia, 31 (5), 1108-1116
DOI 10.1038/leu.2016.360, PubMed 27890936

Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N (2016)
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party
Bone Marrow Transplant, 51 (9), 1259-61
DOI 10.1038/bmt.2016.97, PubMed 27111041

Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2016)
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
Bone Marrow Transplant, 52 (2), 209-215
DOI 10.1038/bmt.2016.266, PubMed 27819688

Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR et al. (2016)
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
J Allergy Clin Immunol, 139 (1), 232-245
DOI 10.1016/j.jaci.2016.05.042, PubMed 27577878

Tvedt TH, Lie SA, Reikvam H, Rye KP, Lindås R, Gedde-Dahl T, Ahmed AB, Bruserud Ø (2016)
Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation
Int J Mol Sci, 17 (11)
DOI 10.3390/ijms17111823, PubMed 27809289

Publications 2015

Bazarbachi A, Labopin M, Kharfan-Dabaja MA, Schwerdtfeger R, Volin L, Bourhis JH, Socié G, Daguindau E, Gedde-Dahl T, Rambaldi A, Karas M, Schlimok G, Blaise D, Chevallier P, Malard F, Schmid C, Esteve J, Nagler A, Mohty M (2015)
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
Haematologica, 101 (1), e34-7
DOI 10.3324/haematol.2015.135681, PubMed 26405153

Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
Ther Drug Monit, 37 (4), 493-500
DOI 10.1097/FTD.0000000000000180, PubMed 25565670

Publications 2014

Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H (2014)
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
Cancer Immunol Immunother, 63 (8), 757-77
DOI 10.1007/s00262-014-1578-z, PubMed 24997173

Hallstensen RF, Bergseth G, Foss S, Jæger S, Gedde-Dahl T, Holt J, Christiansen D, Lau C, Brekke OL, Armstrong E, Stefanovic V, Andersen JT, Sandlie I, Mollnes TE (2014)
Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
Immunobiology, 220 (4), 452-9
DOI 10.1016/j.imbio.2014.11.003, PubMed 25468724

Hjorth-Hansen H, Stenke L, Söderlund S, Dreimane A, Ehrencrona H, Gedde-Dahl T, Gjertsen BT, Höglund M, Koskenvesa P, Lotfi K, Majeed W, Markevärn B, Ohm L, Olsson-Strömberg U, Remes K, Suominen M, Simonsson B, Porkka K, Mustjoki S, Richter J, Nordic CML Study Group (2014)
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
Eur J Haematol, 94 (3), 243-50
DOI 10.1111/ejh.12423, PubMed 25082346

Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
[Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
Tidsskr Nor Laegeforen, 134 (16), 1569-75
DOI 10.4045/tidsskr.13.1415, PubMed 25178233

Publications 2013

Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Blood, 121 (23), 4647-54
DOI 10.1182/blood-2012-11-464503, PubMed 23616624

Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H, Nordic CML Study Group (NCMLSG) (2013)
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
Leukemia, 27 (7), 1520-6
DOI 10.1038/leu.2013.19, PubMed 23328954

Publications 2012

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 47 (12), 1552-7
DOI 10.1038/bmt.2012.63, PubMed 22522568

Publications 2011

Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
Eur J Haematol, 86 (5), 385-95
DOI 10.1111/j.1600-0609.2011.01590.x, PubMed 21332794

Gruber FX, Lundán T, Goll R, Silye A, Mikkola I, Rekvig OP, Knuutila S, Remes K, Gedde-Dahl T, Porkka K, Hjorth-Hansen H (2011)
BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
Med Oncol, 29 (1), 219-26
DOI 10.1007/s12032-010-9781-z, PubMed 21221851

Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, Björeman M, Flogegård M, Koskenvesa P, Lindblom A, Malm C, Mustjoki S, Myhr-Eriksson K, Ohm L, Räsänen A, Sinisalo M, Själander A, Strömberg U, Bjerrum OW, Ehrencrona H, Gruber F, Kairisto V, Olsson K, Sandin F, Nagler A et al. (2011)
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
Blood, 118 (12), 3228-35
DOI 10.1182/blood-2011-02-336685, PubMed 21685374

Publications 2010

Johnsen HE, Klausen TW, Boegsted M, Lenhoff S, Gimsing P, Christiansen I, Gedde-Dahl T, Lindås R, Mellqvist UH, Nordic Myeloma Study Group (2010)
Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group
Clin Lymphoma Myeloma Leuk, 10 (4), 290-6
DOI 10.3816/CLML.2010.n.060, PubMed 20709667

Publications 2009

Andresen PA, Heimdal K, Aaberg K, Eklo K, Ariansen S, Silye A, Fausa O, Aabakken L, Aretz S, Eide TJ, Gedde-Dahl T (2009)
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
J Cancer Res Clin Oncol, 135 (10), 1463-70
DOI 10.1007/s00432-009-0594-4, PubMed 19444466

Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P (2009)
Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases
Acta Haematol, 122 (1), 11-6
DOI 10.1159/000230037, PubMed 19641300

Publications 2008

Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
[Allogeneic stem cell transplantation in acute myelogenous leukemia]
Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
PubMed 18704137

Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
[Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
Tidsskr Nor Laegeforen, 128 (22), 2563-6
PubMed 19023351

Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y, IRIS (International Randomized Interferon vs STI571) Study Group (2008)
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
Blood, 111 (8), 4022-8
DOI 10.1182/blood-2007-10-116475, PubMed 18256322

Publications 2007

Andresen PA, Johansen T, Eide TJ, Gedde-Dahl T (2007)
Gene symbol: APC
Hum Genet, 121 (2), 288
PubMed 17598199

Dahlqvist J, Klar J, Hausser I, Anton-Lamprecht I, Pigg MH, Gedde-Dahl T, Gånemo A, Vahlquist A, Dahl N (2007)
Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis
J Med Genet, 44 (10), 615-20
DOI 10.1136/jmg.2007.050542, PubMed 17557927

Frøyland M, Thompson KM, Thorpe SJ, Sahota SS, Gedde-Dahl T, Bogen B (2007)
A VH4-34+ myeloma protein with weak autoreactivity
Haematologica, 92 (5), 690-3
DOI 10.3324/haematol.10850, PubMed 17488696

Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
Leukemia, 21 (10), 2203-4
DOI 10.1038/sj.leu.2404751, PubMed 17525727

Publications 2006

Frangu M, Gedde-Dahl T, Verder H (2006)
[Epidermolysis bullosa simplex Dowling-Meara]
Ugeskr Laeger, 168 (48), 4222-4
PubMed 17147951

Publications 2005

Gruber FX, Lamark T, Anonli A, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B (2005)
Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
Leukemia, 19 (12), 2159-65
DOI 10.1038/sj.leu.2403983, PubMed 16224487

Mathisen B, Loennechen T, Gedde-Dahl T, Winberg JO (2005)
Fibroblast heterogeneity in collagenolytic response to colchicine
Biochem Pharmacol, 71 (5), 574-83
DOI 10.1016/j.bcp.2005.11.018, PubMed 16378602

Publications 2004

Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B (2004)
Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models
Cancer Immunol Immunother, 53 (9), 759-69
DOI 10.1007/s00262-004-0504-1, PubMed 15088126

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE (2004)
[Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab]
Tidsskr Nor Laegeforen, 124 (6), 768-70
PubMed 15039804

Klar J, Gedde-Dahl T, Larsson M, Pigg M, Carlsson B, Tentler D, Vahlquist A, Dahl N (2004)
Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13
J Med Genet, 41 (3), 208-12
DOI 10.1136/jmg.2003.012567, PubMed 14985385

Koss-Harnes D, Høyheim B, Jonkman MF, de Groot WP, de Weerdt CJ, Nikolic B, Wiche G, Gedde-Dahl T (2004)
Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation
Acta Derm Venereol, 84 (2), 124-31
DOI 10.1080/00015550310007094, PubMed 15206692

Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR (2004)
Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX
Haemophilia, 10 (2), 174-8
DOI 10.1046/j.1365-2516.2003.00857.x, PubMed 14962207

Publications 2003

Virtanen M, Smith SK, Gedde-Dahl T, Vahlquist A, Bowden PE (2003)
Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis
J Invest Dermatol, 121 (5), 1013-20
DOI 10.1046/j.1523-1747.2003.12534.x, PubMed 14708600

Publications 2002

Koss-Harnes D, Høyheim B, Anton-Lamprecht I, Gjesti A, Jørgensen RS, Jahnsen FL, Olaisen B, Wiche G, Gedde-Dahl T (2002)
A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations
J Invest Dermatol, 118 (1), 87-93
DOI 10.1046/j.0022-202x.2001.01591.x, PubMed 11851880

Lind B, Gedde-Dahl T, Tjønnfjord G, Villoutreix BO, Brosstad F (2002)
Protein C deficiency caused by homozygosity for a novel PROC D180G mutation--in vitro expression and structural analysis of the mutation
Thromb Haemost, 88 (4), 632-8
PubMed 12362235

Van Maldergem L, Magré J, Khallouf TE, Gedde-Dahl T, Delépine M, Trygstad O, Seemanova E, Stephenson T, Albott CS, Bonnici F, Panz VR, Medina JL, Bogalho P, Huet F, Savasta S, Verloes A, Robert JJ, Loret H, De Kerdanet M, Tubiana-Rufi N, Mégarbané A, Maassen J, Polak M, Lacombe D, Kahn CR et al. (2002)
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
J Med Genet, 39 (10), 722-33
DOI 10.1136/jmg.39.10.722, PubMed 12362029

Publications 2001

Andresen PA, Gedde-Dahl T, Fausa O, Eide TJ, Heiberg A (2001)
[Genetic analysis in familial adenomatous polyposis]
Tidsskr Nor Laegeforen, 121 (1), 64-8
PubMed 12013617

Magré J, Delépine M, Khallouf E, Gedde-Dahl T, Van Maldergem L, Sobel E, Papp J, Meier M, Mégarbané A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F et al. (2001)
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
Nat Genet, 28 (4), 365-70
DOI 10.1038/ng585, PubMed 11479539

Nordal EJ, Mecklenbeck S, Hausser I, Skranes J, Bruckner-Tuderman L, Gedde-Dahl T (2001)
Generalized dystrophic epidermolysis bullosa: identification of a novel, homozygous glycine substitution, G2031S, in exon 73 of COL7A1 in monozygous triplets
Br J Dermatol, 144 (1), 151-7
DOI 10.1046/j.1365-2133.2001.03966.x, PubMed 11167698

Skotheim RI, Kraggerud SM, Fosså SD, Stenwig AE, Gedde-Dahl T, Danielsen HE, Jakobsen KS, Lothe RA (2001)
Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence
Neoplasia, 3 (3), 196-203
DOI 10.1038/sj.neo.7900153, PubMed 11494113

van Leusden MR, Pas HH, Gedde-Dahl T, Sonnenberg A, Jonkman MF (2001)
Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutation
Lab Invest, 81 (6), 887-94
DOI 10.1038/labinvest.3780297, PubMed 11406649

Virtanen M, Gedde-Dahl T, Mörk NJ, Leigh I, Bowden PE, Vahlquist A (2001)
Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression
Acta Derm Venereol, 81 (3), 163-70
DOI 10.1080/000155501750376221, PubMed 11558869

Publications 2000

Dupuy BM, Gedde-Dahl T, Olaisen B (2000)
DXYS267: DYS393 and its X chromosome counterpart
Forensic Sci Int, 112 (2-3), 111-21
DOI 10.1016/s0379-0738(00)00170-5, PubMed 10940596

Dupuy BM, Gedde-Dahl T, Olaisen B (2000)
DYS393 and its X chromosome counterpart
INT CONGR SER (1193), 67-70

Pigg M, Gedde-Dahl T, Cox DW, Haugen G, Dahl N (2000)
Haplotype association and mutation analysis of the transglutaminase 1 gene for prenatal exclusion of lamellar ichthyosis
Prenat Diagn, 20 (2), 132-7
DOI 10.1002/(sici)1097-0223(200002)20:2<132::aid-pd765>3.0.co;2-0, PubMed 10694685

Publications 1999

Apelland T, Gedde-Dahl T, Dietrichson T (1999)
[Serotonin syndrome with fatal outcome caused by selective serotonin reuptake inhibitors]
Tidsskr Nor Laegeforen, 119 (5), 647-50
PubMed 10095385

Publications 1998

Dupuy BM, Gedde-Dahl T, Olaisen B (1998)
Comparisons of allele frequencies in three hyperpolymorphic STRs between Norwegian Saamis and the main population
INT CONGR SER, 1167, 395-397

Pigg M, Gedde-Dahl T, Cox D, Hausser I, Anton-Lamprecht I, Dahl N (1998)
Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from Norway
Eur J Hum Genet, 6 (6), 589-96
DOI 10.1038/sj.ejhg.5200224, PubMed 9887377

Publications 1997

Koss-Harnes D, Jahnsen FL, Wiche G, Søyland E, Brandtzaeg P, Gedde-Dahl T (1997)
Plectin abnormality in epidermolysis bullosa simplex Ogna: non-responsiveness of basal keratinocytes to some anti-rat plectin antibodies
Exp Dermatol, 6 (1), 41-8
DOI 10.1111/j.1600-0625.1997.tb00144.x, PubMed 9067706

Scheffer H, Stulp RP, Verlind E, van der Meulen M, Bruckner-Tuderman L, Gedde-Dahl T, te Meerman GJ, Sonnenberg A, Buys CH, Jonkman MF (1997)
Implications of intragenic marker homozygosity and haplotype sharing in a rare autosomal recessive disorder: the example of the collagen type XVII (COL17A1) locus in generalised atrophic benign epidermolysis bullosa
Hum Genet, 100 (2), 230-5
DOI 10.1007/s004390050496, PubMed 9254855

Winberg JO, Hammami-Hauasli N, Nilssen O, Anton-Lamprecht I, Naylor SL, Kerbacher K, Zimmermann M, Krajci P, Gedde-Dahl T, Bruckner-Tuderman L (1997)
Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with a missense mutation in the COL7A1 gene
Hum Mol Genet, 6 (7), 1125-35
DOI 10.1093/hmg/6.7.1125, PubMed 9215684

Publications 1996

Chan YM, Cheng J, Gedde-Dahl T, Niemi KM, Fuchs E (1996)
Genetic analysis of a severe case of Dowling-Meara epidermolysis bullosa simplex
J Invest Dermatol, 106 (2), 327-34
DOI 10.1111/1523-1747.ep12342985, PubMed 8601736

Gedde-Dahl T, Trygstad O, Van Maldergem L, Magré J, van der Hagen CB, Olaisen B, Stenersen M, Mevåg B (1996)
Genetics of the Berardinelli-Seip syndrome (congenital generalized lipodystrophy) in Norway: epidemiology and gene mapping. Berardinelli-Seip Study Group
Acta Paediatr Suppl, 413, 52-8
DOI 10.1111/j.1651-2227.1996.tb14266.x, PubMed 8783773

Gjertsen MK, Bakka A, Breivik J, Saeterdal I, Gedde-Dahl T, Stokke KT, Sølheim BG, Egge TS, Søreide O, Thorsby E, Gaudernack G (1996)
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study
Int J Cancer, 65 (4), 450-3
DOI 10.1002/(SICI)1097-0215(19960208)65:4<450::AID-IJC10>3.0.CO;2-E, PubMed 8621226

Jonkman MF, de Jong MC, Heeres K, Steijlen PM, Owaribe K, Küster W, Meurer M, Gedde-Dahl T, Sonnenberg A, Bruckner-Tuderman L (1996)
Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency
Arch Dermatol, 132 (2), 145-50
DOI 10.1001/archderm.132.2.145, PubMed 8629821

Lyngstadaas SP, Nordbo H, Gedde-Dahl T, Thrane PS (1996)
On the genetics of hypodontia and microdontia: synergism or allelism of major genes in a family with six affected members
J Med Genet, 33 (2), 137-42
DOI 10.1136/jmg.33.2.137, PubMed 8929951

Uttam J, Hutton E, Coulombe PA, Anton-Lamprecht I, Yu QC, Gedde-Dahl T, Fine JD, Fuchs E (1996)
The genetic basis of epidermolysis bullosa simplex with mottled pigmentation
Proc Natl Acad Sci U S A, 93 (17), 9079-84
DOI 10.1073/pnas.93.17.9079, PubMed 8799157

Publications 1995

Bruckner-Tuderman L, Nilssen O, Zimmermann DR, Dours-Zimmermann MT, Kalinke DU, Gedde-Dahl T, Winberg JO (1995)
Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain
J Cell Biol, 131 (2), 551-9
DOI 10.1083/jcb.131.2.551, PubMed 7593178

Cox DW, Gedde-Dahl T, Menon AG, Nygaard TG, Tomlinson IM, Peters J, St George-Hyslop PH, Walter MA, Edwards JH (1995)
Report of the second international workshop on human chromosome 14 mapping 1994
Cytogenet Cell Genet, 69 (3-4), 159-74
DOI 10.1159/000133954, PubMed 7698004

Sajantila A, Lahermo P, Anttinen T, Lukka M, Sistonen P, Savontaus ML, Aula P, Beckman L, Tranebjaerg L, Gedde-Dahl T, Issel-Tarver L, DiRienzo A, Pääbo S (1995)
Genes and languages in Europe: an analysis of mitochondrial lineages
Genome Res, 5 (1), 42-52
DOI 10.1101/gr.5.1.42, PubMed 8717054

Publications 1994

Fossum B, Breivik J, Meling GI, Gedde-Dahl T, Hansen T, Knutsen I, Rognum TO, Thorsby E, Gaudernack G (1994)
A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?
Int J Cancer, 58 (4), 506-11
DOI 10.1002/ijc.2910580409, PubMed 7914513

Fossum B, Gedde-Dahl T, Breivik J, Eriksen JA, Spurkland A, Thorsby E, Gaudernack G (1994)
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp)
Int J Cancer, 56 (1), 40-5
DOI 10.1002/ijc.2910560108, PubMed 7903287

Gedde-Dahl T (1994)
Immune responses to p21 ras oncoproteins in man
Institute of Transplantation Immunology, The National Hospital and University of Oslo : Norwegian Cancer Society, Oslo, 1 b. (flere pag.)
BIBSYS 942419537, ISBN 82-7633-046-0

Gedde-Dahl T, Dupuy BM, Jonassen R, Winberg JO, Anton-Lamprecht I, Olaisen B (1994)
Junctional epidermolysis bullosa inversa (locus EBR2A) assigned to 1q31 by linkage and association to LAMC1
Hum Mol Genet, 3 (8), 1387-91
DOI 10.1093/hmg/3.8.1387, PubMed 7987320

Gedde-Dahl T, Nilsen E, Thorsby E, Gaudernack G (1994)
Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras
Cancer Immunol Immunother, 38 (2), 127-34
DOI 10.1007/BF01526208, PubMed 8306368

Gedde-Dahl T, Spurkland A, Fossum B, Wittinghofer A, Thorsby E, Gaudernack G (1994)
T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA
Eur J Immunol, 24 (2), 410-4
DOI 10.1002/eji.1830240221, PubMed 7507844

Gedde-Dahl T, Winberg JO (1994)
Neonatal retention of type VII collagen, transient bullous dermolysis of the newborn and recessive epidermolysis bullosa dystrophica inversa
Br J Dermatol, 130 (5), 685-6
DOI 10.1111/j.1365-2133.1994.tb13127.x, PubMed 8204486

Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
Binding of ras oncogene peptides to purified HLA-DQ (alpha 1*0102, beta 1*0602) and -DR (alpha, beta 1*0101) molecules
Scand J Immunol, 40 (4), 468
DOI 10.1111/j.1365-3083.1994.tb03491.x, PubMed 7939420

Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
Binding of ras oncogene peptides to purified HLA-DQ(alpha 1*0102,beta 1*0602) and -DR(alpha,beta 1*0101) molecules
Scand J Immunol, 39 (6), 607-12
DOI 10.1111/j.1365-3083.1994.tb03420.x, PubMed 8009176

König A, Winberg JO, Gedde-Dahl T, Bruckner-Tuderman L (1994)
Heterogeneity of severe dystrophic epidermolysis bullosa: overexpression of collagen VII by cutaneous cells from a patient with mutilating disease
J Invest Dermatol, 102 (2), 155-9
DOI 10.1111/1523-1747.ep12371754, PubMed 8106746

Spurkland A, Gedde-Dahl T, Hansen T, Vartdal F, Gaudernack G, Thorsby E (1994)
Heterogeneity of T cells specific for a particular peptide/HLA-DQ complex
Hum Immunol, 39 (1), 61-8
DOI 10.1016/0198-8859(94)90102-3, PubMed 8181964

Verrando P, Lissitzky JC, Sarret Y, Winberg JO, Gedde-Dahl T, Schmitt D, Bruckner-Tuderman L (1994)
Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin
Lab Invest, 71 (4), 567-74
PubMed 7967512

Publications 1993

Fossum B, Gedde-Dahl T, Hansen T, Eriksen JA, Thorsby E, Gaudernack G (1993)
Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells
Eur J Immunol, 23 (10), 2687-91
DOI 10.1002/eji.1830231045, PubMed 7691613

Gedde-Dahl T, Fossum B, Eriksen JA, Thorsby E, Gaudernack G (1993)
T cell clones specific for p21 ras-derived peptides: characterization of their fine specificity and HLA restriction
Eur J Immunol, 23 (3), 754-60
DOI 10.1002/eji.1830230328, PubMed 8449222

Gedde-Dahl T, Olsen BH, Thorsby E, Gaudernack G (1993)
Oncogene-derived peptides: a new class of tumor rejection antigens?
Transplant Proc, 25 (1 Pt 2), 1385-6
PubMed 8442151

Hansen T, Spurkland A, Lundin KE, Gjertsen H, Gedde-Dahl T, Qvigstad E, Markussen G, Thorsby E (1993)
Studies of the T-cell receptors of T cells recognizing the same HLA molecule
Transplant Proc, 25 (1 Pt 1), 72
PubMed 8438455

Publications 1992

Bruckner-Tuderman L, Winberg JO, Anton-Lamprecht I, Schnyder UW, Gedde-Dahl T (1992)
Anchoring fibrils, collagen VII, and neutral metalloproteases in recessive dystrophic epidermolysis bullosa inversa
J Invest Dermatol, 99 (5), 550-8
DOI 10.1111/1523-1747.ep12667372, PubMed 1431215

Gedde-Dahl T (1992)
Symposium on epidermolysis bullosa
J Med Genet, 29 (5), 354-5
DOI 10.1136/jmg.29.5.354, PubMed 1349925

Gedde-Dahl T, Eriksen JA, Thorsby E, Gaudernack G (1992)
T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides
Hum Immunol, 33 (4), 266-74
DOI 10.1016/0198-8859(92)90334-j, PubMed 1639630

Gedde-Dahl T, Spurkland A, Eriksen JA, Thorsby E, Gaudernack G (1992)
Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61)
Int Immunol, 4 (11), 1331-7
DOI 10.1093/intimm/4.11.1331, PubMed 1282032

Krajci P, Gedde-Dahl T, Høyheim B, Rogde S, Olaisen B, Brandtzaeg P (1992)
The gene encoding human transmembrane secretory component (locus PIGR) is linked to D1S58 on chromosome 1
Hum Genet, 90 (3), 215-9
DOI 10.1007/BF00220065, PubMed 1487233

Rogde S, Gedde-Dahl T, Teisberg P, Jonassen R, Høyheim B, Olaisen B (1992)
Linkage and association studies with C8A and C8B RFLPs on chromosome 1
Ann Hum Genet, 56 (3), 233-42
DOI 10.1111/j.1469-1809.1992.tb01148.x, PubMed 1360193

Winberg JO, Gedde-Dahl T (1992)
Epidermolysis bullosa simplex: expression of gelatinase activity in cultured human skin fibroblasts
Biochem Genet, 30 (7-8), 401-20
DOI 10.1007/BF00569330, PubMed 1445183

Publications 1991

Rogne S, Myklebost O, Olving JH, Kyrkjebø HT, Jonassen R, Olaisen B, Gedde-Dahl T (1991)
The human genes for complement components 6 (C6) and 9 (C9) are closely linked on chromosome 5
J Med Genet, 28 (9), 587-90
DOI 10.1136/jmg.28.9.587, PubMed 1683409

Publications 1990

Cox DW, Nakamura Y, Gedde-Dahl T (1990)
Report of the committee on the genetic constitution of chromosome 14
Cytogenet Cell Genet, 55 (1-4), 183-8
DOI 10.1159/000133010, PubMed 2073832

Lothe RA, Brøgger A, Gedde-Dahl T (1990)
High-resolution karyotypes of eighteen Norwegian polyposis patients
Cancer Genet Cytogenet, 47 (1), 69-72
DOI 10.1016/0165-4608(90)90264-b, PubMed 2162732

Rogne S, Mevåg B, Gedde-Dahl T, Myklebost O (1990)
Multiple RFLPs of human complement component nine (C9) detected by TaqI
Nucleic Acids Res, 18 (10), 3112
DOI 10.1093/nar/18.10.3112-a, PubMed 1971940

Publications 1989

Andresen PA, Gedde-Dahl T, Bergan A, Berstad T, Sellgren AC (1989)
[A Norwegian polyposis family. From catastrophe to prevention]
Tidsskr Nor Laegeforen, 109 (7-8), 832-5
PubMed 2539657

Gedde-Dahl T, Heim S, Lothe R, Bye R, Geitvik GA, Kyrkjebø HT, Hognestad J, Nygaard K, Bergan A, Olaisen B (1989)
[The polyposis project]
Nord Med, 104 (1), 12-5
PubMed 2536147

Rogne S, Myklebost O, Høyheim B, Olaisen B, Gedde-Dahl T (1989)
The genes for apolipoprotein all (APOA2) and the Duffy blood group (FY) are linked on chromosome 1 in man
Genomics, 4 (2), 169-73
DOI 10.1016/0888-7543(89)90296-6, PubMed 2500391

Winberg JO, Gedde-Dahl T, Bauer EA (1989)
Collagenase expression in skin fibroblasts from families with recessive dystrophic epidermolysis bullosa
J Invest Dermatol, 92 (1), 82-5
DOI 10.1111/1523-1747.ep13071274, PubMed 2535863

Publications 1988

Beighton P, de Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, Hall JG, Hollister DW, Horton W, McKusick VA (1988)
International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986
Am J Med Genet, 29 (3), 581-94
DOI 10.1002/ajmg.1320290316, PubMed 3287925

Cox DW, Gedde-Dahl T (1988)
Report of the committee on the genetic constitution of chromosomes 14 and 15
Cytogenet Cell Genet, 49 (1-3), 90-3
DOI 10.1159/000132656, PubMed 3203557

Garber JE, Li FP, Kingston JE, Krush AJ, Strong LC, Finegold MJ, Bertario L, Bülow S, Filippone A, Gedde-Dahl T (1988)
Hepatoblastoma and familial adenomatous polyposis
J Natl Cancer Inst, 80 (20), 1626-8
DOI 10.1093/jnci/80.20.1626, PubMed 2848134

Gedde-Dahl T, Heim S, Lothe R, Bye R, Brevik K, Geitvik GA, Kyrkjebø HT, Hognestad J, Nygaard K, Bergan A (1988)
[The polyposis project]
Tidsskr Nor Laegeforen, 108 (29), 2465-8
PubMed 2905084

Lothe RA, Nakamura Y, Woodward S, Gedde-Dahl T, White R (1988)
VNTR (variable number of tandem repeats) markers show loss of chromosome 17p sequences in human colorectal carcinomas
Cytogenet Cell Genet, 48 (3), 167-9
DOI 10.1159/000132617, PubMed 2906851

Teisberg P, Jonassen R, Mevåg B, Gedde-Dahl T, Olaisen B (1988)
Restriction fragment length polymorphisms of the complement component C4 loci on chromosome 6: studies with emphasis on the determination of gene number
Ann Hum Genet, 52 (2), 77-84
DOI 10.1111/j.1469-1809.1988.tb01082.x, PubMed 2907852

Publications 1987

Gedde-Dahl T (1987)
The human gene map and genes expressed in the skin
Curr Probl Dermatol, 16, 45-64
DOI 10.1159/000413455, PubMed 3556034

Gedde-Dahl T (1987)
Epidermolysis bullosa syndromes
Curr Probl Dermatol, 16, 129-45
PubMed 3581883

Geitvik GA, Høyheim B, Gedde-Dahl T, Grzeschik KH, Lothe R, Tomter H, Olaisen B (1987)
The Kidd (JK) blood group locus assigned to chromosome 18 by close linkage to a DNA-RFLP
Hum Genet, 77 (3), 205-9
DOI 10.1007/BF00284470, PubMed 2890568

Hovig E, Winberg JO, Fodstad O, Brøgger A, Gedde-Dahl T (1987)
Chromosome 13 instability and esterase D expression in an osteosarcoma cell line
Cancer Genet Cytogenet, 24 (2), 327-34
DOI 10.1016/0165-4608(87)90115-4, PubMed 2878716

Lothe RA, Gedde-Dahl T, Lier ME, Aamdahl S, Bergan A, Stenwig AE, Broegger A (1987)
Loss of one chromosome #13 during development of a polyposis tumor
Cancer Genet Cytogenet, 28 (2), 335-42
DOI 10.1016/0165-4608(87)90220-2, PubMed 2887278

Ropers HH, Gedde-Dahl T, Cox DW (1987)
Report of the committee on the genetic constitution of chromosomes 13, 14, 15 amd 16
Cytogenet Cell Genet, 46 (1-4), 213-41
DOI 10.1159/000132478, PubMed 3507275

Publications 1986

Gedde-Dahl T (1986)
Clinical heterogeneity in epidermolysis bullosa: speculations on causation and consequence for research
J Invest Dermatol, 86 (2), 91-3
DOI 10.1111/1523-1747.ep12284000, PubMed 3745948

Lothe RA, Gedde-Dahl T, Olaisen B, Bakker E, Pearson P (1986)
Very close linkage between D2S1 and ACP1 on chromosome 2p
Ann Hum Genet, 50 (4), 361-7
DOI 10.1111/j.1469-1809.1986.tb01757.x, PubMed 3481680

Rogde S, Olaisen B, Gedde-Dahl T, Teisberg P (1986)
The C8A and C8B loci are closely linked on chromosome 1
Ann Hum Genet, 50 (2), 139-44
DOI 10.1111/j.1469-1809.1986.tb01032.x, PubMed 3435043

Rogne S, Myklebost O, Olaisen B, Gedde-Dahl T, Prydz H (1986)
Confirmation of the close linkage between the loci for human apolipoproteins AI and AIV by the use of a cloned cDNA probe and two restriction site polymorphisms
Hum Genet, 72 (1), 68-71
DOI 10.1007/BF00278820, PubMed 3002953

Winberg JO, Gedde-Dahl T (1986)
Gelatinase expression in generalized epidermolysis bullosa simplex fibroblasts
J Invest Dermatol, 87 (3), 326-9
DOI 10.1111/1523-1747.ep12524396, PubMed 3016106

Publications 1985

Cox DR, Gedde-Dahl T (1985)
Report of the Committee on the Genetic Constitution of Chromosomes 13, 14, 15 and 16
Cytogenet Cell Genet, 40 (1-4), 206-41
DOI 10.1159/000132175, PubMed 3864595

Eriksson AW, Foltmann B, Frants RR, Gedde-Dahl T, Samloff IM, Taggart RT (1985)
Nomenclature Committee report: pepsinogens. Nomenclature Committee of Human Gene Mapping Conference
Prog Clin Biol Res, 173, 41-2
PubMed 3983197

Gedde-Dahl T (1985)
On chromosome mapping of human pepsinogen gene loci
Prog Clin Biol Res, 173, 101-6
PubMed 3983190

Gedde-Dahl T, Hannisdal E, Klepp OH, Grøttum KA, Waksvik H, Fosså SD, Stenwig AE, Brøogger A (1985)
Testicular neoplasms occurring in four brothers. A search for a genetic predisposition
Cancer, 55 (9), 2005-9
DOI 10.1002/1097-0142(19850501)55:9<2005::aid-cncr2820550930>3.0.co;2-l, PubMed 2983872

Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brøgger A, Gedde-Dahl T, Cavenee WK (1985)
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition
Proc Natl Acad Sci U S A, 82 (18), 6216-20
DOI 10.1073/pnas.82.18.6216, PubMed 2994066

Olaisen B, Gedde-Dahl T, Teisberg P, Thorsby E, Siverts A, Jonassen R, Wilhelmy MC (1985)
A structural locus for coagulation factor XIIIA (F13A) is located distal to the HLA region on chromosome 6p in man
Am J Hum Genet, 37 (1), 215-20
PubMed 2858156

Rogde S, Mevåg B, Teisberg P, Gedde-Dahl T, Tedesco F, Olaisen B (1985)
Genetic polymorphism of complement component C8
Hum Genet, 70 (3), 211-6
DOI 10.1007/BF00273444, PubMed 3879968

Publications 1984

Gedde-Dahl T, Olaisen B, Teisberg P, Wilhelmy MC, Mevåg B, Helland R (1984)
The locus for apolipoprotein E (apoE) is close to the Lutheran (Lu) blood group locus on chromosome 19
Hum Genet, 67 (2), 178-82
DOI 10.1007/BF00272996, PubMed 6745937

Myklebost O, Rogne S, Olaisen B, Gedde-Dahl T, Prydz H (1984)
The locus for apolipoprotein CII is closely linked to the apolipoprotein E locus on chromosome 19 in man
Hum Genet, 67 (3), 309-12
DOI 10.1007/BF00291359, PubMed 6088388

Schamaun O, Olaisen B, Mevåg B, Gedde-Dahl T, Ehnholm C, Teisberg P (1984)
The two apolipoprotein loci apo A-I and apo A-IV are closely linked in man
Hum Genet, 68 (2), 181-4
DOI 10.1007/BF00279311, PubMed 6500569

Publications 1983

Olaisen B, Teisberg P, Jonassen R, Thorsby E, Gedde-Dahl T (1983)
Gene order and gene distances in the HLA region studied by the haplotype method
Ann Hum Genet, 47 (4), 285-92
DOI 10.1111/j.1469-1809.1983.tb00998.x, PubMed 6418058

Schamaun O, Olaisen B, Gedde-Dahl T, Teisberg P (1983)
Genetic studies of an apoA-I lipoprotein variant
Hum Genet, 64 (4), 380-3
DOI 10.1007/BF00292371, PubMed 6413385

Publications 1982

Gedde-Dahl T (1982)
Final eradication of tuberculosis in Norway?
J Oslo City Hosp, 32 (9), 107-9
PubMed 7143132

Olaisen B, Teisberg P, Gedde-Dahl T (1982)
Fibrinogen gamma chain locus is on chromosome 4 in man
Hum Genet, 61 (1), 24-6
DOI 10.1007/BF00291325, PubMed 6957371

Olaisen B, Teisberg P, Gedde-Dahl T (1982)
The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man
Hum Genet, 62 (3), 233-6
DOI 10.1007/BF00333526, PubMed 7169215

Weitkamp LR, Berg K, Gedde-Dahl T, Hulten MA, McAlpine PJ, Sandberg K, Spence MA (1982)
Workshop on mapping by classical methods
Prog Clin Biol Res, 103 Pt A, 141-4
PubMed 7163191

Publications 1981

Gedde-Dahl T (1981)
Sixteen types of epidermolysis bullosa. On the clinical discrimination, therapy and prenatal diagnosis
Acta Derm Venereol Suppl (Stockh), 95, 74-87
PubMed 6953718

Gedde-Dahl T, Frants RR, Olaisen B, Eriksson AW, van Loghem E, Lamm L (1981)
The Gm--Pi linkage heterogeneity in view of Pi M subtypes
Ann Hum Genet, 45 (2), 143-53
DOI 10.1111/j.1469-1809.1981.tb00316.x, PubMed 6797346

Nordhagen R, Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1981)
C4 haplotype products and partial inhibition of anti-Rodgers sera
J Immunogenet, 8 (6), 485-91
DOI 10.1111/j.1744-313x.1981.tb00957.x, PubMed 7334218

Olaisen B, Siverts A, Jonassen R, Mevåg B, Gedde-Dahl T (1981)
The ESD polymorphism: further studies of the ESD2 and ESD5 allele products
Hum Genet, 57 (4), 351-3
DOI 10.1007/BF00281682, PubMed 7286974

Olaisen B, Teisberg P, Jonassen R, Gedde-Dahl T, Moen T, Thorsby E (1981)
Complement loci of the HLA complex. Studies on families with intra-HLA crossovers and haplotype associations
Hum Immunol, 2 (3), 247-54
DOI 10.1016/0198-8859(81)90016-1, PubMed 6455398

Publications 1980

Korsnes L, Gedde-Dahl T (1980)
Genetics of pepsinogen I
Ann Hum Genet, 43 (3), 199-212
DOI 10.1111/j.1469-1809.1980.tb01554.x, PubMed 6767433

Korsnes L, Gedde-Dahl T, Olaisen B, Thorsby E, Olving J, Siverts A, Bratlie A (1980)
Genetic linkage relation to the pepsinogen Pg5 locus
Ann Hum Genet, 44 (2), 185-94
DOI 10.1111/j.1469-1809.1980.tb00957.x, PubMed 7316469

Nordhagen R, Olaisen B, Teisberg P, Gedde-Dahl T (1980)
Association between the electrophoretically-determined C4M haplotype product and partial inhibition of anti-Cha
J Immunogenet, 7 (4), 301-6
DOI 10.1111/j.1744-313x.1980.tb00723.x, PubMed 6161195

Teisberg P, Olaisen B, Gedde-Dahl T, Thorsby E, Nordhagen R (1980)
Further investigations on the genetics of the C+ protein polymorphism
Immunobiology, 158 (1-2), 45-9
DOI 10.1016/s0171-2985(80)80037-4, PubMed 7203519

Publications 1979

Fischer T, Gedde-Dahl T (1979)
Epidermolysis bullosa simplex and mottled pigmentation: a new dominant syndrome. I. Clinical and histological features
Clin Genet, 15 (3), 228-38
DOI 10.1111/j.1399-0004.1979.tb00972.x, PubMed 421361

Olaisen B, Teisberg P, Jonassen R, Gedde-Dahl T (1979)
The C4 system: formal and population genetics
Hum Genet, 50 (2), 187-92
DOI 10.1007/BF00390240, PubMed 511133

Olaisen B, Teisberg P, Nordhagen R, Michaelsen T, Gedde-Dahl T (1979)
Human complement C4 locus is duplicated on some chromosomes
Nature, 279 (5715), 736-7
DOI 10.1038/279736a0, PubMed 450123

Olving JH, Olaisen B, Gedde-Dahl T, Teisberg P (1979)
Genetic linkage relations of the sixth component of complement (C6)
Hum Genet, 46 (2), 181-92
DOI 10.1007/BF00291920, PubMed 422202

Publications 1978

Bennick A, Gedde-Dahl T, brøgger A (1978)
Mapping with B-cell hybrids
Cytogenet Cell Genet, 22 (1-6), 661-5
DOI 10.1159/000131047, PubMed 313313

Gedde-Dahl T, Hansteen IL, Fagerhol MK, Olaisen B (1978)
Regional chromosome 12 mapping: information from a family with a (12;21) reciprocal translocation
Cytogenet Cell Genet, 22 (1-6), 478-81
DOI 10.1159/000131002, PubMed 752526

Gedde-Dahl T, Korsnes L, Thorsby E, Olaisen B, Bratlie A, Siverts A (1978)
Pepsinogens: new variant and linkage relationships to chromosome 6 markers
Cytogenet Cell Genet, 22 (1-6), 301-3
DOI 10.1159/000130959, PubMed 752491

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1978)
Genetic polymorphism of the second component of human complement (C2): presentation of a modified typing technique and data on C2 phenotype distribution, linkage genetics, and haplotype associations a Norwegian family material
Hum Genet, 42 (3), 301-5
DOI 10.1007/BF00291310, PubMed 669711

Olaisen B, Teisberg P, Jonassen R, Gedde-Dahl T, Olving JH, Siverts A, Bratlie A, Thorsby E (1978)
Structural complement factor loci and the HLA region
Cytogenet Cell Genet, 22 (1-6), 421-7
DOI 10.1159/000130988, PubMed 752517

Publications 1977

Bauer EA, Gedde-Dahl T, Eisen AZ (1977)
The role of human skin collagenase in epidermolysis bullosa
J Invest Dermatol, 68 (3), 119-24
DOI 10.1111/1523-1747.ep12492226, PubMed 190326

Gedde-Dahl T, Thorsby E (1977)
HLA and epidermolysis bullosa
Arch Dermatol, 113 (12), 1722-3
DOI 10.1001/archderm.113.12.1722, PubMed 596909

Olving JH, Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1977)
Nonlinkage between C6 and chromosome 6 markers
Hum Genet, 37 (2), 125-9
DOI 10.1007/BF00393574, PubMed 885533

Teisberg P, Olaisen B, Jonassen R, Gedde-Dahl T, Thorsby E (1977)
The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region
J Exp Med, 146 (5), 1380-9
DOI 10.1084/jem.146.5.1380, PubMed 925607

Publications 1976

Brogger A, Gedde-Dahl T, Olaisen B (1976)
Linkage data on 3q11 and 15ps fluorescence markers
Cytogenet Cell Genet, 16 (1-5), 275-6
DOI 10.1159/000130608, PubMed 975889

Elston RC, Namboodiri KK, Lange K, Gedde-Dahl T (1976)
Effect of age on the Gm:Pi linkage
Cytogenet Cell Genet, 16 (1-5), 298-301
DOI 10.1159/000130614, PubMed 1086184

Elston RC, Namboodiri KK, Lange K, Gedde-Dahl T (1976)
Effect of age on the gm:pi linkage
Birth Defects Orig Artic Ser, 12 (7), 298-301
PubMed 1088254

Gedde-Dahl T, Giles CM, Thorsby E, Olaisen B, Robson EB (1976)
Chido blood group and the HLA region
Cytogenet Cell Genet, 16 (1-5), 307-10
DOI 10.1159/000130616, PubMed 975894

Gedde-Dahl T, Giles CM, Thorsby E, Olaisen B, Robson EB (1976)
Chido blood group and the HLA region
Birth Defects Orig Artic Ser, 12 (7), 307-10
PubMed 1024629

Gedde-Dahl T, Robson EB (1976)
Rodgers blood group and the HLA region
Cytogenet Cell Genet, 16 (1-5), 311-2
DOI 10.1159/000130617, PubMed 975896

Gedde-Dahl T, Robson EB (1976)
Rodgers blood group and the HLA region
Birth Defects Orig Artic Ser, 12 (7), 311-2
PubMed 1024630

Giles CM, Gedde-Dahl T, Robson EB, Thorsby E, Olaisen B, Arnason A, Kissmeyer-Nielsen F, Schreuder I (1976)
Rga (Rodgers) and the HLA region: linkage and associations
Tissue Antigens, 8 (2), 143-9
PubMed 968900

Hashimoto I, Gedde-Dahl T, Schnyder UW, Anton-Lamprecht I (1976)
Ultrastructural studies in epidermolysis bullosa hereditaria. II. Dominant dystrophic type of Cockayne and Touraine
Arch Dermatol Res (1975), 255 (3), 285-95
DOI 10.1007/BF00561499, PubMed 942257

Hashimoto I, Gedde-Dahl T, Schnyder UW, Anton-Lamprecht I (1976)
Ultrastructural studies in epidermolysis bullosa hereditaria. IV. Recessive dystrophic types with junctional blistering. (Infantile or Herlitz-Pearson type and adult type)
Arch Dermatol Res (1975), 257 (1), 17-32
DOI 10.1007/BF00569110, PubMed 1008602

Hashimoto I, Schnyder UW, Anton-Lamprecht I, Gedde-Dahl T, Ward S (1976)
Ultrastructural studies in epidermolysis bullosa hereditaria. III. Recessive dystrophic types with dermolytic blistering (Hallopeau-Siemens types and inverse type)
Arch Dermatol Res (1975), 256 (2), 137-50
DOI 10.1007/BF00567360, PubMed 962387

Olaisen B, Gedde-Dahl T, Thorsby E (1976)
Localization of the human GLO gene locus
Hum Genet, 32 (3), 301-4
DOI 10.1007/BF00295820, PubMed 939550

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1976)
Bf locus and the HLA region
Cytogenet Cell Genet, 16 (1-5), 345-6
DOI 10.1159/000130628, PubMed 975905

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1976)
Bf locus and the HLA region
Birth Defects Orig Artic Ser, 12 (7), 345-6
PubMed 1024638

Teisberg P, Akesson I, Olaisen B, Gedde-Dahl T, Thorsby E (1976)
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6
Nature, 264 (5583), 253-4
DOI 10.1038/264253a0, PubMed 1088823

Publications 1975

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
The Gm-Pi linkage: a summary estimate
Cytogenet Cell Genet, 14 (3-6), 327-8
DOI 10.1159/000130373, PubMed 53124

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
The Gm-Pi linkage: a summary estimate
Birth Defects Orig Artic Ser, 11 (3), 157-8
PubMed 54196

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
Improved estimate of the Gm-Pi linkage
Ann Hum Genet, 39 (1), 43-50
DOI 10.1111/j.1469-1809.1975.tb00106.x, PubMed 810069

Hashimoto I, Anton-Lamprecht I, Gedde-Dahl T, Schnyder UW (1975)
Ultrastructural studies in epidermolysis bullosa heriditaria. I. Dominant dystrophic type of Pasini
Arch Dermatol Forsch, 252 (3), 167-78
PubMed 1155959

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1975)
The Bf locus in the HLA region of chromosome 6: linkage and association studies
Humangenetik, 30 (4), 291-6
DOI 10.1007/BF00275141, PubMed 1218859

Teisberg P, Olaisen B, Gedde-Dahl T, Thorsby E (1975)
On the localization of the Gb locus within the MHS region of chromosome No. 6
Tissue Antigens, 5 (4), 257-61
DOI 10.1111/j.1399-0039.1975.tb01472.x, PubMed 1154360

Weitkamp LR, Lovrien EW, Olaisen B, Fenger K, Gedde-Dahl T, Sorensen SA, Conneally PM, Bias WB, Ott J (1975)
Linkage relations of the loci for the MN blood group and red cell acid phosphatase
Cytogenet Cell Genet, 14 (3-6), 446-50
DOI 10.1159/000130403, PubMed 1192835

Weitkamp LR, Lovrien EW, Olaisen B, Fenger K, Gedde-Dahl T, Sorensen SA, Conneally PM, Bias WB, Ott J (1975)
Linkage relations of the loci for the MN blood group and red cell acid phosphatase
Birth Defects Orig Artic Ser, 11 (3), 276-80
PubMed 1203495

Publications 1974

Gedde-Dahl T, Teisberg P, Thorsby E (1974)
C3 polymorphism: genetic linkage relations
Clin Genet, 6 (1), 66-72
DOI 10.1111/j.1399-0004.1974.tb00632.x, PubMed 4426132

Olaisen B, Gedde-Dahl T (1974)
Gpt-EBS1 linkage group. General linkage relations
Hum Hered, 24 (2), 178-85
DOI 10.1159/000152650, PubMed 4425507

Publications 1973

Gedde-Dahl T (1973)
Population structure in Norway. Inbreeding, distance and kinship
Hereditas, 73 (2), 211-32
DOI 10.1111/j.1601-5223.1973.tb01083.x, PubMed 4713280

Olaisen B, Gedde-Dahl T (1973)
GPT--epidermolysis bullosa simplex (EBS Ogna) linkage in man
Hum Hered, 23 (3), 189-96
DOI 10.1159/000152573, PubMed 4760576

Publications 1972

Gedde-Dahl T, Fagerhol MK, Cook PJ, Noades J (1972)
Autosomal linkage between the Gm and Pi loci in man
Ann Hum Genet, 35 (4), 393-9
PubMed 5073686

Publications 1971

Bjercke O, Christensen O, Gedde-Dahl T (1971)
[The standpoint of the Committee for Superannuation Benefits]
Tidsskr Nor Laegeforen, 91 (18), 1425-8
PubMed 5568071

Gedde-Dahl T (1971)
Phenotype-genotype correlations in epidermolysis bullosa
Birth Defects Orig Artic Ser, 7 (8), 107-17
PubMed 5173253

Gedde-Dahl T, Natvig JB, Gundersen K (1971)
Inheritance of Gm(g) and a gene complex Gm a Gm g weak
Clin Genet, 2 (6), 356-66
DOI 10.1111/j.1399-0004.1971.tb00297.x, PubMed 5155313

Publications 1970

Gedde-Dahl T (1970)
Epidermolysis bullosa: a clinical, genetic and epidemiological study
Universitetsforlaget, Oslo, 180 s.
BIBSYS 865008124

Publications 1969

Fagerhol MK, Gedde-Dahl T (1969)
Genetics of the Pi serum types. Family studies of the inherited variants of serum alpha-1-antitrypsin
Hum Hered, 19 (4), 354-9
DOI 10.1159/000152238, PubMed 5366282

Publications 1968

Gedde-Dahl T, Monn E (1968)
A note on the PGM-1-PTC linkage relation
Acta Genet Stat Med, 18 (5), 420
DOI 10.1159/000152163, PubMed 5755851

Publications 1967

Gedde-Dahl T (1967)
[Single gene diseases: general considerations]
Tidsskr Nor Laegeforen, 87 (5), Suppl:431-8
PubMed 4859969

Gedde-Dahl T (1967)
[Diseases showing an irregular family pattern]
Tidsskr Nor Laegeforen, 87 (5), Suppl:477-83
PubMed 6046761

Gedde-Dahl T (1967)
[Consanguinity and disease]
Tidsskr Nor Laegeforen, 87 (5), Suppl:498-504
PubMed 6046765

Gedde-Dahl T (1967)
[Genetic counseling in hereditary diseases]
Tidsskr Nor Laegeforen, 87 (5), Suppl:507-11
PubMed 6046766

Gedde-Dahl T, Monn E (1967)
Linkage relations of the phosphoglucomutase PGM locus in man. Probable linkage to phenylthiocarbamid (PTC) taster locus
Acta Genet Stat Med, 17 (6), 482-94
DOI 10.1159/000152102, PubMed 6072882

Publications 1966

Gedde-Dahl T (1966)
[Late and early diagnosis of tuberculosis situations]
Tuberkuloza, 18 (1-3), 68-72
PubMed 16296069

Gedde-Dahl T, Niewiarowska M, Stormorken H (1966)
Parameters of hemostasis in Epidermolysis bullosa: absence of significant deviations from normal
Acta Derm Venereol, 46 (5), 436-42
PubMed 4162945

Publications 1965

GEDDE-DAHL T (1965)
[AAGE JOHANSEN IN MEMORIAM]
Tidsskr Nor Laegeforen, 85, 57
PubMed 14282767

Gedde-Dahl T, Berg K (1965)
Linkage in man: the Inv and the Lp serum type systems
Nature, 208 (5015), 1126
DOI 10.1038/2081126a0, PubMed 5870581

Publications 1963

GEDDE-DAHL T (1963)
[Epidermolysis bullosa congenita simplex with hyperkeratosis palmoplantaris. Therapeutic efforts in a case with generalized blister formation]
Tidsskr Nor Laegeforen, 83, 113-6
PubMed 13946969

GEDDE-DAHL T (1963)
[Epidermolysis bullosa hereditaria: orientation and challenge]
Tidsskr Nor Laegeforen, 83, 95-100
PubMed 13946970

Publications 1960

Gedde-Dahl T (1960)
En hjertesak: radioforedrag ... 1.februar 1960
[slo], 8 s.
BIBSYS 060611073

Publications 1957

GEDDE-DAHL T (1957)
[Consequences of the altered epidemiological situation]
Nord Med, 58 (38), 1421-3
PubMed 13484033

Publications 1956

GEDDE-DAHL T (1956)
[Tuberculosis, past, present and future]
Tidsskr Nor Laegeforen, 76 (11), 381-7
PubMed 13337827

Publications 1955

GEDDE-DAHL T (1955)
[Gerontology in Norway]
Nord Med, 54 (27), 1051-3
PubMed 13244886

Publications 1952

GEDDE-DAHL T (1952)
Tuberculous infection in the light of tuberculin matriculation
Am J Hyg, 56 (2), 139-214
DOI 10.1093/oxfordjournals.aje.a119547, PubMed 12985565

Gedde-Dahl T (1952)
Plan for ordning av helsekontrollen på landsbygden: bearb. efter foredrag i Norsk hygienisk forening 10. nov.1951
Oslo, 12 s.
BIBSYS 060611243

Publications 1951

GEDDE-DAHL T (1951)
[The duration of BCG allergy]
Nord Med, 45 (4), 122-3
PubMed 14827211

GEDDE-DAHL T (1951)
[Declining tuberculosis incidence and control organization]
Nord Med, 46 (31), 1155-8
PubMed 14863714

GEDDE-DAHL T (1951)
[Chaos or system in rural health control]
Tidsskr Nor Laegeforen, 71 (17), 550-1
PubMed 14884153

Publications 1950

GEDDE-DAHL T (1950)
[Possibility of determining the effect of mass BCG vaccination]
Nord Med, 43 (10), 444-5
PubMed 14780459

Publications 1949

GEDDE-DAHL T (1949)
[Tuberculosis the foundations of the work]
Nord Med, 41 (24), 1055-8
PubMed 18135112